Scarica l'app Stockscreener
7.19
3.10%
-0.23
Dopo l'orario di chiusura:
7.26
0.07
+0.97%
CorMedix Inc Borsa (CRMD) Ultime notizie
Diluted net income available to common stockholders of CorMedix Inc. – HAN:19KA - TradingView
Non-operating income (total) of CorMedix Inc. – HAN:19KA - TradingView
ETFs Investing in CorMedix Inc. Stocks - TradingView
CorMedix Inc. Balance Sheet – HAN:19KA - TradingView
CorMedix Inc. Revenue Breakdown – HAN:19KA - TradingView
Form 4 CorMedix Inc For: 27 September - Investing.com India
Form 4 CorMedix Inc For: 27 September By Investing.com - Investing.com Nigeria
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - Eastern Progress
The Technical Signals Behind (CRMD) That Institutions Follow - Stock Traders Daily
Cormedix Inc Lobbying Profile, 2015 - OpenSecrets
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
CorMedix Inc (CRMD) Stock Price Target & Forecast - TradingKey
CorMedix (NASDAQ:CRMD) Shares Gap UpStill a Buy? - MarketBeat
CRMD Shareholder Alert: Rosen, a Longstanding and Trusted Firm, Encourages CorMedix Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionCRMD - TMX Newsfile
Oppenheimer Initiates CorMedix at Outperform With $15 Price Target - Moomoo
CorMedix (NASDAQ:CRMD) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Oppenheimer initiates CorMedix stock coverage with outperform rating By Investing.com - Investing.com Canada
Oppenheimer initiates CorMedix stock coverage with outperform rating - Investing.com
CorMedix Inc. (CRMD) Edges Lower to $7.72 as Shares Test Support Above $7.33Option Breadth - careplusvn.com
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
Cormedix Stock Price Forecast. Should You Buy CRMD? - StockInvest.us
CorMedix Inc (NASDAQ: CRMD) Share Price, CRMD Stock News, CRMD Share Price & Updates - kalkine.ca
CorMedix Inc. (CRMD) Stock Analysis: Biotech Innovator With A 97.69% Potential Upside - DirectorsTalk Interviews
CorMedix (CRMD) Down -1.15% — 3 Warning Signs Investors Should See 2026-09-17Small Cap Breakouts - careplusvn.com
Trading the Move, Not the Narrative: (CRMD) Edition - Stock Traders Daily
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
CorMedix at Wells Fargo 21st annual healthcare conference: growth, risk By Investing.com - Investing.com Canada
CorMedix Inc. (CRMD) Latest Stock News & Headlines - Yahoo Finance
CorMedix at Wells Fargo 21st annual healthcare conference: growth, risk - Investing.com
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged - Yahoo Finance
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet - Yahoo Finance
Bank of New York Mellon Corp Takes Position in CorMedix Inc $CRMD - MarketBeat
CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge - Stocktwits
243,232 Shares in CorMedix Inc $CRMD Purchased by Empowered Funds LLC - MarketBeat
CorMedix (CRMD) COO holds 270K shares after cost-covering share withholding - Stock Titan
CorMedix will meet investors in Boston for a Wells Fargo chat - Stock Titan
BlackRock Inc. Acquires Shares of 6,324,111 CorMedix Inc $CRMD - MarketBeat
Equity award costs paid in stock at CorMedix (CRMD) - Stock Titan
CorMedix (CRMD) Upgraded to Buy: Here's Why - Yahoo Finance
CorMedix (CRMD) CFO uses shares to cover taxes - Stock Titan
CRMD|CorMedix Inc|Price:8.300|Chg%:-0.010 - tradingkey.com
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Eastern Progress
CorMedix (CRMD) Results at a Glance: EPS Exceeds Its Estimate in Latest Trading; Shares Move Lower 0.72% on the DayTech Earnings Analysis - vinanet.vn
CorMedix (CRMD) Q2 2026 Earnings Call Transcript - AOL.com
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):